{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T13:54:03Z","timestamp":1784642043248,"version":"3.55.0"},"reference-count":27,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Sciences"],"abstract":"<jats:p>Background: Venous thromboembolism (VTE) is a thromboinflammatory disorder involving coordinated activation of coagulation, endothelial dysfunction, and inflammatory signaling. Low-molecular-weight heparins (LMWHs) may exert pharmacological effects beyond anticoagulation. This study compared enoxaparin, bemiparin, and tinzaparin and explored potential multi-target mechanisms using molecular docking, network pharmacology, and enrichment analyses. Methods: In this retrospective cohort study, patients with acute VTE treated with therapeutic-dose LMWHs were analyzed. Stabilized IPTW based on multinomial propensity scores was used to reduce baseline imbalance between treatment groups. Clinical recovery was assessed using the Clinical Severity Score (CSS). Thromboinflammatory biomarkers (MPV, hs-CRP, NLR, fibrinogen) were evaluated during follow-up. Molecular docking, STRING\/Cytoscape-based protein\u2013protein interaction, and enrichment analyses were performed. Results: Median time to symptom resolution was 31 days with enoxaparin, 28 days with bemiparin, and 24 days with tinzaparin (log-rank p &lt; 0.001). Recovery was faster with bemiparin (HR 1.28, 95% CI 1.05\u20131.56) and tinzaparin (HR 1.72, 95% CI 1.41\u20132.10). Tinzaparin showed greater reductions in hs-CRP, MPV, NLR, and fibrinogen (all p &lt; 0.05) and less analgesic use beyond 10 days (19.7% vs. 27.0% and 33.2%; p &lt; 0.001). Docking analyses identified plausible conformations (root-mean-square deviation, RMSD \u2264 2 \u00c5). Given the structural flexibility and heterogeneous chain length of LMWHs, rigid docking algorithms may not fully capture biologically relevant conformations. Therefore, docking results should be interpreted as qualitative interaction mapping rather than quantitative binding affinity estimation. Network analysis highlighted F3, TNF, IL6, and VWF, while enrichment analyses suggested involvement of cytokine signaling, leukocyte migration, and thromboinflammatory pathways. Conclusions: LMWH therapy was associated with improved thromboinflammatory markers and clinical recovery, with tinzaparin showing comparatively more favorable thromboinflammatory biomarker trajectories and recovery dynamics within the limitations of this observational analysis. Integrated clinical and in silico findings provide hypothesis-generating insights into potential multi-target pharmacological effects beyond anticoagulation; however, these observations should be interpreted cautiously and require experimental validation.<\/jats:p>","DOI":"10.3390\/medsci14020260","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:53:10Z","timestamp":1779191590000},"page":"260","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Thromboinflammatory and Pharmacological Effects of Low-Molecular-Weight Heparins in Acute Venous Thromboembolism: An Integrated Clinical and In Silico Analysis"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7767-9029","authenticated-orcid":false,"given":"Lutfi Cagatay","family":"Onar","sequence":"first","affiliation":[{"name":"Department of Cardiovascular Surgery, Dr. Ismail Fehmi Cumalioglu City Hospital, Republic of Turkey Ministry of Health, Tekirdag 59020, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6340-5441","authenticated-orcid":false,"given":"Ersin","family":"Guner","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Konya Numune Hospital, Republic of Turkey Ministry of Health, Konya 42060, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irem Ozten","family":"Dalkiran","sequence":"additional","affiliation":[{"name":"Department of Midwifery, University of Health Sciences, Istanbul 34668, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2003-6337","authenticated-orcid":false,"given":"Ibrahim","family":"Yilmaz","sequence":"additional","affiliation":[{"name":"Unit of Pharmacovigilance, Dr. Ismail Fehmi Cumalioglu City Hospital, Republic of Turkey Ministry of Health, Tekirdag 59020, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,19]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"12586","DOI":"10.1080\/07391102.2023.2167114","article-title":"Network pharmacology- and molecular simulation-based exploration of therapeutic targets and mechanisms of heparin for the treatment of sepsis\/COVID-19","volume":"41","author":"Fang","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3608","DOI":"10.1016\/j.jtha.2023.08.020","article-title":"New insights into the binding of PF4 to long heparin oligosaccharides in ultralarge complexes using mass spectrometry","volume":"21","author":"Shi","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"ref_3","first-page":"101609","article-title":"High molecular weight heparin-induced angiogenesis mainly mediated via basic fibroblast growth factor-2\u2014An in-vivo (CAM) and in-silico analysis","volume":"37","author":"Manjunathan","year":"2024","journal-title":"Biochem. Biophys. Rep."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Magnusdottir, U., Yang Jonatansdottir, Y., Oskarsson, K.R., Hjorleifsson, J.G., Einarsson, J.M., and Thormodsson, F.R. (2025). Characterization of YKL-40 binding to extracellular matrix glycosaminoglycans. Mar. Drugs, 23.","DOI":"10.3390\/md23100379"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"Aguilar-Pineda, J.A., Paco-Coralla, S.G., Febres-Molina, C., Gamero-Begazo, P.L., Shrivastava, P., Vera-L\u00f3pez, K.J., Davila-Del-Carpio, G., L\u00f3pez-C, P., G\u00f3mez, B., and Lino Cardenas, C.L. (2022). In silico analysis of the antagonist effect of enoxaparin on the ApoE4-amyloid-beta (A\u03b2) complex at different pH conditions. Biomolecules, 12.","DOI":"10.3390\/biom12040499"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"122797","DOI":"10.1016\/j.carbpol.2024.122797","article-title":"Characterization of the mechanisms governing heparin-bovine serum albumin complex interactions and associated anticoagulant activity","volume":"348","author":"Zhang","year":"2025","journal-title":"Carbohydr. Polym."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"149233","DOI":"10.1016\/j.ijbiomac.2025.149233","article-title":"Molecular regulation of coagulation by heparin-bound plasma Latexin","volume":"335","author":"Huang","year":"2026","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/prot.26448","article-title":"Interactions of heparin derivatives with recombinant human keratinocyte growth factor: Structural stability and bioactivity effect study","volume":"91","author":"Kalhor","year":"2023","journal-title":"Proteins"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3892\/br.2024.1886","article-title":"Network pharmacology analysis and clinical verification of Panax notoginseng saponins in deep venous thrombosis prevention","volume":"22","author":"Yan","year":"2024","journal-title":"Biomed. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/jth.13171","article-title":"Discovery and characterization of an antibody directed against exosite I of thrombin","volume":"14","author":"Baglin","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"4661","DOI":"10.1073\/pnas.0711055105","article-title":"Molecular basis of thrombin recognition by protein C inhibitor revealed by the 1.6-\u00c5 structure of the heparin-bridged complex","volume":"105","author":"Li","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0092-8674(00)00138-0","article-title":"Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1","volume":"103","author":"Somers","year":"2000","journal-title":"Cell"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1126\/science.1083901","article-title":"Hexameric structure and assembly of the interleukin-6\/IL-6 alpha-receptor\/gp130 complex","volume":"300","author":"Boulanger","year":"2003","journal-title":"Science"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"8277","DOI":"10.1038\/ncomms9277","article-title":"Atomic description of the immune complex involved in heparin-induced thrombocytopenia","volume":"6","author":"Cai","year":"2015","journal-title":"Nat. Commun."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/380041a0","article-title":"The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor","volume":"380","author":"Banner","year":"1996","journal-title":"Nature"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.1073\/pnas.95.8.4134","article-title":"A dimeric crystal structure for the N-terminal two domains of intercellular adhesion molecule-1","volume":"95","author":"Casasnovas","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1107\/S0907444901011209","article-title":"A new conformation of the integrin-binding fragment of human VCAM-1 crystallizes in a highly hydrated packing arrangement","volume":"57","author":"Taylor","year":"2001","journal-title":"Acta Crystallogr. D Biol. Crystallogr."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","article-title":"The STRING database in 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest","volume":"51","author":"Szklarczyk","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: A software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Chin, C.H., Chen, S.H., Wu, H.H., Ho, C.W., Ko, M.T., and Lin, C.Y. (2014). cytoHubba: Identifying hub objects and sub-networks from complex interactome. BMC Syst. Biol., 8.","DOI":"10.1186\/1752-0509-8-S4-S11"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"W90","DOI":"10.1093\/nar\/gkw377","article-title":"Enrichr: A comprehensive gene set enrichment analysis web server 2016 update","volume":"44","author":"Kuleshov","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_22","first-page":"D845","article-title":"The DisGeNET knowledge platform for disease genomics: 2019 update","volume":"48","author":"Ronzano","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ymeth.2014.11.020","article-title":"DISEASES: Text mining and data integration of disease-gene associations","volume":"74","author":"Tsafou","year":"2015","journal-title":"Methods"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Bu, C., Pan, L., Chi, L., Pomin, V.H., Dordick, J.S., Wang, C., and Zhang, F. (2026). Probing glycosaminoglycan-protein interactions: Applications of surface plasmon resonance. Biosensors, 16.","DOI":"10.3390\/bios16020071"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Junker, F., and Rother, S. (2025). From native glycosaminoglycans to mimetics: Design, mechanisms, and biomedical applications. Biomolecules, 15.","DOI":"10.3390\/biom15111518"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"114218","DOI":"10.1016\/j.intimp.2025.114218","article-title":"Beyond coagulation: Coagulation protease factor VIIa in cytoprotective response","volume":"150","author":"Chatterjee","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Wu, J., Wang, Z., Shao, W., and Mo, J. (2025). Bridging inflammation and venous thrombosis: The NLRP3 inflammasome connection. Front. Cardiovasc. Med., 12.","DOI":"10.3389\/fcvm.2025.1584745"}],"container-title":["Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3271\/14\/2\/260\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:21:26Z","timestamp":1779193286000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3271\/14\/2\/260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,19]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["medsci14020260"],"URL":"https:\/\/doi.org\/10.3390\/medsci14020260","relation":{},"ISSN":["2076-3271"],"issn-type":[{"value":"2076-3271","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,19]]}}}